CSI (Clinical Scenario Investigation): Hyperkalemia

Similar documents
2019 Home Hemodialysis Standing Orders

Nursing Care of the Dialysis Patient. Adrian Hordon, MSN, RN

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

Normal range of serum potassium is meq/l true hyperkalemia manifests clinically as : Clinical presentation : muscle and cardiac dysfunction

Evaluation of AVF and AVG

Module 10 Troubleshooting Guide

Nephrology / Urology. Hyperkalemia Causes and Definition Lecturio Online Medical Library. Definition. Epidemiology of Hyperkalemia.

St George Hospital Renal Department Guideline: INTERNAL ONLY ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS

AMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

Electrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine

Explorations fonctionnelles des abords vasculaires pour hémodialyse

CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018

Medical Director/Surgeon as Partners WebEx February 11, 2010

K+ Ann Crawford, RN, PhD, CNS, CEN

ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM

Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2

Diagnosis: Allergies with reaction type:

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

Hyponatremia and Hypokalemia

Module 7 Your Blood Work

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital

Hyperkalemia Protect, Shift, and Eliminate

Fundamentals of DIALYSIS

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018

CCRN Review - Renal. CCRN Review - Renal 10/16/2014. CCRN Review Renal. Sodium Critical Value < 120 meq/l > 160 meq/l

Assessment, Monitoring, and. Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008

Calcium (Ca 2+ ) mg/dl

Active UMMC Protocols

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006

RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University

DEFINITIONS FOR FLUID STATUS & TARGET WEIGHT

Medical therapy of AKI complications. Refik Gökmen AKI Academy 18 October 2014

There are no shortcuts to Dialysis

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates

Critical Thinking. Beat the Clock!

HD Scanning: Velocities and Volume Flow

Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy

WATER, SODIUM AND POTASSIUM

Module 11 Medical Emergencies

Can We Achieve Precision Solute Control with CRRT?

St George Hospital Renal Department Internal Only

Potassium A NNA VINNIKOVA, M. D.

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

GUIDELINE FOR HAEMODIALYSIS PRESCRIPTION FOR NEW PATIENTS COMMENCING HAEMODIALYSIS

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

Achieving Equilibrium in ESRD Patients

Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis

5/18/2017. Specific Electrolytes. Sodium. Sodium. Sodium. Sodium. Sodium

Nursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)

Can We Achieve Precision Solute Control with CRRT?

Acute Stroke with Alteplase Administration Order Set

Final Case Study: Renal Disease Due 3/19/14 60 points

Acute Kidney Injury. Elaine Go, RN, MSN, CNN-NP. Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca

Chronic Maintenance In-Center Hemodialysis Standing Orders

PP-US-DSE Relypsa, Inc. All rights reserved. Relypsa and the Relypsa logo are trademarks of Relypsa, Inc.

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care


Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Lutonix in AV fistula and Early look AV IDE trial data

Client going into fluid volume. Fluid replacement = 24 hour fluid loss +.

Clinical Pearls in Renal Medicine

Chronic Maintenance In-Center Hemodialysis Standing Orders

Vascular Access Study Overview and Implementation

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

Adult Home Hemodialysis Standing Orders

MANITOBA RENAL PROGRAM

MANITOBA RENAL PROGRAM

MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

A case of nonfatal non-collapsed patient with extreme hyperkalaemia

Section 3: Prevention and Treatment of AKI

Bare Metal Stents vs Stent Grafts

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter

HEMODIALYSIS. Nursing 246 Adapted from Lewis Chapter 47 Donna Geiger, RN, MSN, FNP

Paediatric Nephrology Date of submission March 2014

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001

Hyperkalemia a silent killer? PD Dr. med. Andreas Kistler Kantonsspital Frauenfeld

Acid Base Balance by: Susan Mberenga RN, BSN, MSN

AV Fistula for Dialysis

GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES

Arteriovenous fistula cannulation by buttonhole technique using dull needle

Modes of Extracorporeal Therapies For ESRD Patients

Tale of Neglected Aneurysm

Nephrology Dialysis Transplantation

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019

III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000

Routine Clinic Lab Studies

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Adult Home Hemodialysis Standing Orders

ONLINE HEMODIALYSIS TRAINING SESSION 2

Nursing Process Focus: Patients Receiving Heparin

Unit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration

Transcription:

CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care Program 12 th Annual Nephrology Education Day, April 27 th, 2011

CSI Objectives review the case of Ms. K., hemodialysis (HD) patient, with K + Examine the physical evidence (labs) Explore the contribution of all possible suspects (causes of K + ) Heighten awareness regarding the clinical importance of exploring all causes of K + in HD patients

Case Review Ms. K. is a 60 year old female with ESRD 2 DM AV fistula loves potatoes Despite dietary counseling, frequent lab results K + ~6.0 Presented to an ER after a fall at home

Physical Evidence: Labs Na 133 K >10 no hemolysis; repeated K = 8.0 HCO 3 21 Urea: 23.9 Creatinine 1074 Glucose, random 7.2 Albumin 38 Hgb 122 g/l WBC 5.78 Platelets 198 Troponin 0.06 range < 0.10 INR 1.03

Signs and Symptoms Weakness Depressed deep tendon reflexes Palpitations Bradycardia Sudden cardiac arrest Nausea Vomiting Paresthesias Generalized weakness Paralysis Fatigue

Normal ECG

K + = 9.4 ECG

K+ : The Suspects FALSE ELEVATIONS TRUE ELEVATIONS - Tight tourniquet - Sample hemolysis - Leukocytosis - Thrombocytosis Decreased or impaired potassium excretion - K + sparing diuretics High K + intake - Supplements, salt substitutes K + shifts out of cells to extracelluar space - Acidosis - Tissue trauma (rhabdomyolysis) - Malignant cell lysis

K + Management Strategies Severe life threatening emergency Protect the heart IV Calcium gluconate or calcium chloride Shift the K + into the cells Bicarbonate, Regular insulin, D50 Facilitate removal of K + from the body GI: cation exchange resin binders Caution: colonic necrosis Urine Hemodialysis Address the underlying cause

Potassium- Quick Review Major electrolyte in the intracellular space (98%); 1 muscle cells Remaining potassium is in the extracelluar fluid Constantly moving in and out of the cell via the Na-K pump Kidney excretes 90% to 95% of daily intake; GI the remainder ~5% http://www.daviddarling.info/encyclopedia/s/sodium-potassium_pump.html

Hemodialysis HD prescription: 1.0 K + dialysate, glucose 8.33 mmol/l, Ca 1.25, HCO 3-40, blood pump speed 400 ml/min Heparin 1000 u bolus; 1000 u/hr Dialyzed for 4 hours Circuit clotted twice Post dialysis lytes = K + 8.4, no hemolysis Why?

K + : The Suspects (Causes) Pseudohyperkalemia X Decreased potassium excretion X High K + intake X K + shifts out of cells X Pt fell; but no rhabdomyolysis no musculoskeletal injuries just dialyzed

Why is her K + still elevated? alarms during HD circuit clotted twice no known prolonged bleeding post HD no difficulty with cannulation What phenomenon should we suspect to be contributing to K +?

New Suspect: Recirculation Definition dialyzed blood returning through the venous needle re-enters the extracorporeal circuit through the arterial needle without returning to the systemic circulation

Hyperkalemia & AV Access AV Access: frequently overlooked as a cause of hyperkalemia Recirculation Stenosis Thrombosis

The Process: AV Access Surveillance Edema of the extremity with AV access Dynamic pressure monitoring Prolonged post venipuncture bleeding Failure of the vein to collapse with elevation of the AV access arm Changes in the thrill or pulse of the access

http://www.kidney.org/patients/plu/plu_online_images/hemodiagram.jpg Access recirculation

Assessing Recirculation Does blood appear to be concentrated/darker than usual during HD; clotted circuits? Flush saline through the circuit: Is saline being pulled in through the arterial access after it leaves the venous needle? Hydraulic compression between the 2 needles http://www.google.ca/imgres?imgurl=http://www.uninet.edu/cin2000/conferences/angoso/angosofig7.gif&imgrefurl=http://www.uninet.edu/cin2000/conferences/angoso/angoso.html&usg= UpXqcByiEEqmXCI60- ffqbish5s=&h=273&w=281&sz=15&hl=en&start=31&zoom=1&tbnid=1ldwkjqb69xy3m:&tbnh=111&tbnw=114&prev=/images%3fq%3dpictures%2bof%2bdialysis%2bav%2baccess%26start%3d20%26hl%3den%26sa%3dn %26tbs%3Disch:1&itbs=1

Hydraulic compression

AV Access Recirculation: Causes Inadequate arterial inflow High grade venous stenoses Improper needle placement Too close AV access flow is less than blood flow in the dialysis machine CSN Guidelines: Jindal, Chan, Deziel, et al., (2006)

20/20 Hindsight What would have been some cues signaling the occurrence of something going on with Ms. K s access prior to her visit to ER? Log sheets Dynamic pressure monitoring Kt/V, PRU

Dynamic Pressure Monitoring First 2 to 5 minutes Do not activate UFR Set blood flow rate 200 ml/min Goal to enable early identification of stenoses within the AV access

Dynamic Pressure Monitoring Review HD log sheet trends of arterial and venous pressures AP,VP ranges: depend on the needle gauge being used Must show a trend outside of the target range 3 times in succession

Needle Gauge and Dynamic Pressure Monitoring Needle Qb (ml/min) Range 14g 200 A= -50 to -70 V= 50 to 70 15g 200 A= -70 to -90 V=70 to 90 16g 200 A= -90 to -120 V= 90 to 120 17g 200 A= -120 to -150 V= 120 to -150

Log Sheet: Dynamic Pressure Monitoring Time BP Target Loss UF rate Total fld removed Blood Flow ml/min Arterial Pressures Venous pressures 200-10 110 0740 150/84 1.6 L 0.4-370 -70 200 0840 162/85 1.6 L 0.4-400 360-100 210 0940 155/85 1.6 0.4-800 360-120 230

Log Sheet: Dynamic Pressure Monitoring Time BP Target Loss UF rate Total fld removed Blood Flow ml/min Arterial Pressures Venous pressures 200 0 110 0805 142/84 2.6 L 0.65-370 -70 200 0905 126/71 2.6 L 0.65-700 360-100 210 1005 138/84 2.6 L 0.65-1300 360-80 240

Log Sheet: Dynamic Pressure Monitoring Time BP Target Loss UF rate Total fld removed Blood Flow ml/min Arterial Pressures Venous pressures 200-10 130 0800 137/74 2.4 L 0.6-370 -70 200 0900 139/69 2.4 L 0.6-600 360-100 210 1000 118/64 2.4 L 0.6 1200 340-90 240

Relationship between Access Flow and Venous and Arterial Pressures A V Blood flow Stenosis at arterial anastamosis Qb = 200 ml/min Expect to see high negative arterial pressures, low venous pressures

Relationship between Access Flow and Venous and Arterial Pressures A V Blood flow Stenosis risk of access thrombosis Qb = 200 ml/min in the first 2 to 5 minutes Expect to see normal or normal /low venous pressures Low (near zero) arterial pressures

Relationship between Access Flow and Venous and Arterial Pressures A V Blood flow Stenosis at venous outflow Qb = 200 ml/min Expect to see low (near zero) arterial pressures, high venous pressures

Impression and Plan K + secondary to access recirculation Cues were present with low AP and elevated VP over 3 consecutive HD sessions Angioplasty: multiple recurrent stenoses in venous outflow and at cephalic arch stent Follow-up access flows and recirculation ASAP post intervention Monthly access flows and recirculation studies

Final Thoughts RNs role is invaluable in early detection and early intervention of the potentially lethal impact of hyperkalemia With hyperkalemia, consider all potential sources: Intake Output Meds Dialysis Access Underlying medical condition

Final Thoughts Dialysis Access Evaluate trends in arterial and venous pressures at BPS 200 ml/min Follow-up reason for changes in PRU/Kt/V Check access flows and recirculation routinely, prn Become familiar with patient s access history, recurrent interventions, frequency of the interventions Do access flows ASAP after intervention Is it time to consider another access?

Final Thoughts Ongoing monitoring at the bedside, assessing trends in addition to correcting stenosis may : improve patency rates of the AV access reduce the risk of access thrombosis reduce rate of access failure (KDOQI, 2006)

References Jindal, K. Chan, C.T., Deziel, C., Hirsch, D, Soroka, S.D., Tonelli, M, Culleton, B. (2006). Candaian Society of Nephrology Clinical Practice Guidelines. Vascular Access. Journal of American Society of Nephrololgy, 17: S1 S27. National Kidney Foundation 2006 Updates Clinical Practice Guidelines and Recommendations. Vascular Access Guideline 4.

Acknowledgements St. Michael s Hospital : Hemodialysis nurses, physicians (Marc Goldstein and Sandra Donnelly) Multidisciplinary team